Beyond TNBC, activating tumor-endogenous ERβ by treating mice bearing orthotopically implanted inflammatory breast cancer tumors with LY500307 led to reduced lung metastasis (Figure 4B) [65]. This evidence concerns the gene ESR2 and neoplasm.